STEVEN MICHAEL OPAL
Physician in Pawtucket, RI

License number
Rhode Island CMD06676
Issued Date
Sep 9, 2002
Expiration Date
6, 2018
Category
Physician
Type
CSR-Allopathic Physician (MD)
Address
Address
Pawtucket, RI
Education
Union University (Albany Medical College), Jan 6, 1976

Personal information

See more information about STEVEN MICHAEL OPAL at radaris.com
Name
Address
Phone
Steven Opal, age 74
11 Briarwood Dr, Barrington, RI 02806
Steven M Opal, age 73
11 Briarwood Dr, Barrington, RI 02806

Professional information

Steven M Opal Photo 1

Dr. Steven M Opal, Pawtucket RI - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
Memorial Hosp RI Infcts Dss
111 Brewster St, Pawtucket 02860
(401) 729-2545 (Phone)
Certifications:
Infectious Disease, 1984, Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Memorial Hosp RI Infcts Dss
111 Brewster St, Pawtucket 02860
Memorial Hospital of Rhode Island
111 Brewster St, Pawtucket 02860
Education:
Medical School
Albany Medical College
Graduated: 1976
Fitzsimons Army Medical Center
Walter Reed Army Medical Center


Steven M Opal Photo 2

Steven M Opal, Pawtucket RI

Specialties:
Internist
Address:
111 Brewster St, Pawtucket, RI 02860
Education:
Albany Medical College - Doctor of Medicine
Walter Reed Army Medical Center - Fellowship - Infectious Disease (Internal Medicine)
University of Colorado Hospital-Anschutz Inpatient Pavilion - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)


Steven Opal Photo 3

Steven Opal, Pawtucket RI

Work:
Memorial Hospital Ri
111 Brewster St, Pawtucket, RI 02860


Steven Opal Photo 4

Pharmaceutical Product For The Treatment Of Sepsis

US Patent:
6315999, Nov 13, 2001
Filed:
Jun 2, 1994
Appl. No.:
8/253217
Inventors:
Jerald C. Sadoff - Washington DC
Steven Michael Opal - Pawtucket RI
Alan S. Cross - Washington DC
Mark William Bodmer - Oxfordshire, GB
Assignee:
Solvay, S.A. - Brussels
International Classification:
A61K 39395, A61K 3940, C07K 1400
US Classification:
4241451
Abstract:
An antibody to tumor necrosis factor-. alpha. (anti-TNF) and an antibody to bacterial lipopolysaccharide (anti-LPS) used together in a neutropenic rat model of sepsis are shown to enhance survival of the rats relative to either antibody used alone. Pharmaceutical products including each of the components are therefore of utility in therapy of sepsis. The anti-LPS antibody included may be specific for the O-specific clain of a particular bacterial lipopolysaccharide (serotype specific antibody) but preferably recognizes the core glycolipid of lipopolysaccharide.